Literature DB >> 10464074

Chronic beryllium disease and cancer risk estimates with uncertainty for beryllium released to the air from the Rocky Flats Plant.

P D McGavran1, A S Rood, J E Till.   

Abstract

Beryllium was released into the air from routine operations and three accidental fires at the Rocky Flats Plant (RFP) in Colorado from 1958 to 1989. We evaluated environmental monitoring data and developed estimates of airborne concentrations and their uncertainties and calculated lifetime cancer risks and risks of chronic beryllium disease to hypothetical receptors. This article discusses exposure-response relationships for lung cancer and chronic beryllium disease. We assigned a distribution to cancer slope factor values based on the relative risk estimates from an occupational epidemiologic study used by the U.S. Environmental Protection Agency (EPA) to determine the slope factors. We used the regional atmospheric transport code for Hanford emission tracking atmospheric transport model for exposure calculations because it is particularly well suited for long-term annual-average dispersion estimates and it incorporates spatially varying meteorologic and environmental parameters. We accounted for model prediction uncertainty by using several multiplicative stochastic correction factors that accounted for uncertainty in the dispersion estimate, the meteorology, deposition, and plume depletion. We used Monte Carlo techniques to propagate model prediction uncertainty through to the final risk calculations. We developed nine exposure scenarios of hypothetical but typical residents of the RFP area to consider the lifestyle, time spent outdoors, location, age, and sex of people who may have been exposed. We determined geometric mean incremental lifetime cancer incidence risk estimates for beryllium inhalation for each scenario. The risk estimates were < 10(-6). Predicted air concentrations were well below the current reference concentration derived by the EPA for beryllium sensitization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10464074      PMCID: PMC1566450          DOI: 10.1289/ehp.99107731

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  16 in total

Review 1.  Immune mechanisms in beryllium lung disease.

Authors:  S D Deodhar; B P Barna
Journal:  Cleve Clin J Med       Date:  1991 Mar-Apr       Impact factor: 2.321

2.  Beryllium report disputed by listed author.

Authors:  R J Smith
Journal:  Science       Date:  1981-02-06       Impact factor: 47.728

Review 3.  The clinical significance of beryllium.

Authors:  A J Aller
Journal:  J Trace Elem Electrolytes Health Dis       Date:  1990-03

4.  Chronic beryllium disease: a continuing epidemiologic hazard.

Authors:  F M Hasan; H Kazemi
Journal:  Chest       Date:  1974-03       Impact factor: 9.410

5.  Metabolically consistent breathing rates for use in dose assessments.

Authors:  D W Layton
Journal:  Health Phys       Date:  1993-01       Impact factor: 1.316

6.  Epidemiological aspects of beryllium-induced nonmalignant lung disease: a 30-year update.

Authors:  M Eisenbud; J Lisson
Journal:  J Occup Med       Date:  1983-03

7.  Beryllium disease: a clinical perspective.

Authors:  H L Hardy
Journal:  Environ Res       Date:  1980-02       Impact factor: 6.498

8.  Lung cancer incidence among patients with beryllium disease: a cohort mortality study.

Authors:  K Steenland; E Ward
Journal:  J Natl Cancer Inst       Date:  1991-10-02       Impact factor: 13.506

9.  Epidemiology of beryllium sensitization and disease in nuclear workers.

Authors:  K Kreiss; M M Mroz; B Zhen; J W Martyny; L S Newman
Journal:  Am Rev Respir Dis       Date:  1993-10

10.  Beryllium: A Chronic Problem.

Authors: 
Journal:  Environ Health Perspect       Date:  1994-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.